[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2016 Global Molecular Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies-Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing

November 2015 | 1398 pages | ID: 27B314DC5CCEN
Venture Planning Group

US$ 27,600.00 US$ 34,500.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This new seven-country study from VPGMarketResearchcontains 1,398 pages, 194 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnosticsmarket during the next five years. Highlights
  • Business and technological trends in seven major markets: France, Germany, Italy, Japan, Spain, UK, and US
  • Five-year test volume and sales forecasts
  • Market shares of leading competitors
  • Feature comparison of major analyzers
  • Profiles of market players and start-up firms developing innovative technologiesand products
  • Specific product and business opportunities for instrument and consumable suppliers. RationaleThe molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Geographic Coverage
  • France
  • Germany
  • Italy
  • Japan
  • Spain
  • UK
  • USAWorldwide Market Overview
  • Laboratories performing DNA sequencing and molecular diagnostic testingby country and market segment.
  • Five-year test volume and sales projections by country. Market Segmentation Analysis
  • Sales and market shares of major suppliers of molecular diagnosticreagent kits and components.
  • Five-year test volume and sales forecasts for major applications, including:
  • Infectious Diseases
  • Forensic Testing
  • Cancer
  • Paternity Testing/HLA Typing
  • Genetic Diseases
  • Others
  • Five-year test volume and sales projections for over 30 NAT assays.
  • A comprehensive analysis of the sequencing market, by country and laboratory segment, including:
  • Industrial
  • Academic
  • Government
  • Commercial
  • Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers, by country. Product/Technology Review
  • Comparison of leading molecular diagnosticanalyzers from Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Roche, Tecan and other suppliers.
  • Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods, including:
  • PCR
  • bDNA
  • SDA
  • NASBA
  • TMA
  • SSSR, and others
  • LCR
  • Worldwide listings of companies, universities and research centers developing new molecular
  • diagnostictechnologies and products. Competitive Assessments
  • Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.
  • Comprehensive listings of companies developing and marketing molecular diagnostics products, by test and application. Opportunities and Strategic Recommendations
  • Specific new product development opportunities with potentially significant market appealduring the next five years.
  • Design criteria for new products.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
  • Business planning issues and concerns. MethodologyThis report is based on a combination of primary and secondary information sources, including interviews with laboratory directors and executives of leading diagnostic companies and start-up firms developing innovative technologies and products in the U.S., five major European countries and Japan. In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearchs proprietary data base was conducted. Contains 1398 pages and 194 tables
  • 1. INTRODUCTION

    2. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

    A. INSTRUMENTATION

    B. Reagent Kits and Test Systems/panels
    C. Computers, Software and Automation
    D. Auxiliary Products

    3. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

    4. ALTERNATIVE MARKET PENETRATION STRATEGIES

    A. Internal Development
    B. Collaborative Arrangements
    C. University Contracts
    D. Distribution Strategies For Decentralized Testing Markets

    5. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

    A. Market Maturity
    B. Cost Containment
    C. Competition
    D. Technological Edge And Limitations
    E. Patent Protection
    F. Regulatory Constraints
    G. Decentralized Testing Market Challenges

    6. WORLDWIDE MARKET AND TECHNOLOGY REVIEW

    A. DNA Sequencing
      1. INTRODUCTION
      2. SEQUENCING METHODS
      3. AUTORADIOGRAPHY
      4. THE HUMAN GENOME PROJECT
      5. SEQUENCING AUTOMATION
      6. IMAGE SCANNERS
      7. FLUORESCENT DETECTION
      8. GENE PROFILING
      9. GENE EXPRESSION
      10. POLYMORPHISM SCREENING
      11. PROTEIN INTERACTION NETWORKS
    B. DNA and RNA Probe Technologies
      1. BASIC PRINCIPLES
      2. PROBE PREPARATION
      3. THE DNA PROBE TEST
      4. TEST FORMATS
      5. LABELING TECHNIQUES
      6. AMPLIFICATION METHODS
    C. Detection Technologies
      1. RADIOACTIVE METHODS
        a. Overview
        b. Major Isotopes
          P-32
          S-35
          H-3
          I-125
      2. NON-ISOTOPIC METHODS
        a. Enzymatic Labels
        b. Chemical Labeling
    @ Indirect Chemical Labeling
    @ Direct Chemical Labeling
        c. Fluorescence
        d. Chemiluminescence
        e. Electrical Conductivity
    D. Molecular Diagnostic INSTRUMENTATION Review
      1. ABBOTT LCX
      2. BECKMAN COULTER/BIOMEK FK
      3. BD VIPER SYSTEM WITH XTR TECHNOLOGY
      4. BD INNOVA
      5. BECTON DICKINSON SDA
      6. BIOMERIEUX NUCLISENS EASYMAG
      7. BIOMERIEUX NUCLISENS EASYQ AND MINIMAG
      8. BIO-RAD GENESCOPE
      9. CEPHEID GENEXPERT
      10. CURETIS UNYVERO
      11. GENMARK DX ESENSOR XT-8
      12. HOLOGIC/GEN-PROBE PANTHER
      13. HOLOGIC/GEN-PROBE TIGRIS/DTS
      14. HTG MOLECULAR EDGE
      15. LIFE TECHNOLOGIES QUANTSTUDI      DX
      16. QIAGEN QIASYMPHONY RGQ
      17. ROCHE COBAS AMPLICOR
      18. ROCHE COBAS TAQMAN
      19. ROCHE COBAS TAQMAN
      20. ROCHE COBAS TAQMAN AMPLIPREP
      21. ROCHE LIGHCYCLER
      22. ROCHE COBAS 4800
      23. ROCHE COBAS S
      24. SIEMENS VERSANT
      25. TECAN LS SERIES
    E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
      Liquid Transportation and Mixing
      Separation
      Reaction
      Detection
    F. Pharmacogenomics
    G. Major Applications
      1. MICROBIOLOGY/INFECTIOUS DISEASES
        a. Overview
        b. Major Infectious Diseases
          AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
          Adenovirus
          Aeromonas
          Anthrax/Bacillus Anthracis
          Arboviruses
          Babesiosis
          Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
          Blastocystis Hominis
          Brucella
          Campylobacter
          Candida
          Chagas Disease
          Chancroid
          Chlamydia
          Clostridium Difficile
          Coronaviruses
          Coxsackieviruses
          Creutzfeldt-Jakob’s Disease
          Cryptosporidium Parvum
          Cyclospora Cayetanensis
          Cytomegalovirus
          Ebola Virus
          E. Coli
          EchoVirus
          Encephalitis
          Enteroviruses
          Epstein-Barr Virus
          Giardia Lamblia
          Gonorrhea
          Granuloma Inguinale
          Hantavirus
          Helicobacter Pylori
          Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, ALT/SGPT
          Herpes Simplex Virus
          Human Herpes Virus-6 (HHV-6)
          Influenza Viruses
          Legionella
          Lyme Disease
          Lymphogranuloma Venereum (LGV)
          Malaria
          Measles (Rubeola)
          Meningitis
          Microsporidium
          Mononucleosis
          Mumps
          Mycoplasma
          Papillomaviruses
          Parvovirus B19
          Pneumonia
          Polyomaviruses
          Pseudomonas Aeruginosa
          Rabies
          Respiratory Syncytial Virus (RSV)
          Rhinoviruses
          Rotavirus
          Rubella
          Salmonellosis
          Septicemia
          Shigellosis
          Staphylococcus Aureus
          Streptococci
          Syphilis
          Toxoplasmosis
          Trichomonas Vaginalis
          Tuberculosis
          Vibrio
          West Nile Virus
          Yersina
      2. CANCER TESTING
        a. Overview
        b. Major Cancer Types
          Prostate
          Lung
          Colon and Rectum
          Breast
          Skin
          Uterine
          Leukemia
          Oral
        c. Oncogenes
    @ Abl/abl-bcr
          AIB1
          BCL-2
          BRCA1
          CD44
    @ C-fos
    @ C-myb
    @ C-myc
          CYP17

    @ Erb-B
          HPC1
          N-myc

          P40
          P51
          P53
          PIK3CA
          PTI-1
    @ Ras
          Reg
    @ Sis
    @ Src
      3. GENETIC DISEASES
        a. Overview
        b. Nucleic Acid Amplification
        c. Chromosome Imaging
        d. Genomics Technologies
        e. Proteomics Technologies
        f. Current Pharmacogenomic Tests
        g. Future Pharmacogenomic Testing
        h. Major Diseases
          Achondroplasia
          Autosomal Dominant Polycystic Kidney Disease
          Cancer
          Cosmetogenomics
          Cystic Fibrosis
          Down's Syndrome
          Duchenne and Becker Muscular Dystrophy
          Factor V (Leiden)
          Factor IX Deficiency
          Fragile X Syndrome
          Heart Disease
          Hemochomatosis
          Hemophilia
          Huntington's Disease
          Maternal-Fetal Incompatibility
          Multiple Endocrine Neoplasia
          Phenylketonuria (PKU)
          Polycystic Kidney Disease (PKD)
          Prenatal Screening
          Retinitis Pigmentosa
          Retinoblastoma
          Sickle Cell Anemia
          Spinal Muscular Atrophy
          Vitamin B12 Metabolism
        i. Social Issues and Concerns
      4. FORENSIC TESTING
        a. Overview
        b. Multilocus and Single Locus Probes
          Multilocus Probes
          Single Locus Probes
          PCR and RFLP
        c. The FBI
        d. DNA Profile Data Banks
          U.S.A.
          U.K.
        e. Judicial Implementation
        f. Major Crime Categories
        g. Factors Contributing to the DNA Probe Market Expansion
          Technology Availability
          Use of Hair as Evidence
        h. Wildlife Forensics
      5. PATERNITY TESTING/HLA TYPING
      6. OTHER APPLICATIONS
        a. Disease Susceptibility Testing
        b. Cardiovascular Diseases
        c. Diabetes
        d. Alzheimer's Disease
        e. Periodontal Disease
        f. Plasma Purification
        g. Organ Transplantation
        h. Water Contamination
        i. Other
    H. Competing/complementing
      1. MONOCLONAL ANTIBODIES/IMMUNOASSAYS
      2. RNA PROBES
      3. TWO-DIMENSIONAL ELECTROPHORESIS
      4. FLOW CYTOMETRY

    7. WORLDWIDE MARKET OVERVIEW

      1. BUSINESS ENVIRONMENT
      2. MARKET STRUCTURE
      3. MARKET SIZE AND GROWTH

    8. FRANCE MOLECULAR DIAGNOSTICS MARKET

    A. EXECUTIVE SUMMARY
    B. Business Environment
    C. Market Structure
    D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

    9. GERMANY MOLECULAR DIAGNOSTICS MARKET

    A. EXECUTIVE SUMMARY
    B. Business Environment
    C. Market Structure
    D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

    10. ITALY MOLECULAR DIAGNOSTICS MARKET

    A. EXECUTIVE SUMMARY
    B. Business Environment
    C. Market Structure
    D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

    11. JAPAN MOLECULAR DIAGNOSTICS MARKET

    A. EXECUTIVE SUMMARY
    B. Business Environment
    C. Market Structure
    D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

    12. SPAIN MOLECULAR DIAGNOSTICS MARKET

    A. EXECUTIVE SUMMARY
    B. Business Environment
    C. Market Structure
    D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

    13. U.K. MOLECULAR DIAGNOSTICS MARKET

    A. EXECUTIVE SUMMARY
    B. Business Environment
    C. Market Structure
    D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

    14. U.S.A. MOLECULAR DIAGNOSTICS MARKET

    A. EXECUTIVE SUMMARY
    B. Business Environment
    C. Market Structure
    D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

    15. COMPETITIVE ASSESSMENTS

      Abbott
      Affymetrix
      Agilent Technologies
      Applied Gene Technologies
      Arca Biopharma
      Beckman Coulter/Danaher
      Becton Dickinson
      Biokit
      bioMerieux
      Bio-Rad
      Biotest
      Cepheid
      CellMark Forensics/LabCorp
      Decode Genetics
      Diadexus
      Eiken
      Elitech Group
      Enzo
      Exact Sciences
      Fujirebio
      Grifols
      Hologic/Gen-Probe
      Illumina
      Kreatech/Leica
      Li-Cor Biosciences
      Monogram Biosciences/LabCorp
      Myriad Genetics
      Ortho-Clinical Diagnostics
      Perkin Elmer/Caliper
      Proteome Sciences
      Qiagen
      Roche
      Scienion
      Sequenom
      Shimadzu
      Siemens
      Sierra Molecular
      Takara Bio
      Tecan Group
      Thermo Fisher

    16. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING MOLECULAR DIAGNOSTIC TECHNOLOGIES

    LIST OF TABLES

    Major Companies Developing or Marketing AIDS Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Adenovirus Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Bartonella Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Campylobacter Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Candida Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Chlamydia Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Clostridium Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Coronavirus Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing CMV Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Echovirus Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Enterovirus Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing EBV Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Giardia Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Hantavirus Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Helicobacter Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Hepatitis Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Herpes Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Influenza Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Legionella Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Measles Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Meningitis Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Mumps Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Pneumonia Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing RSV Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Rotavirus Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Rubella Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Salmonella Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Septicemia Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Shigella Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Streptococci Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Syphilis Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Trichomonas Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic and Other Direct Identification Tests Oncogenes Potential Application in Cancer Diagnosis
    Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
    Major Companies Developing or Marketing Molecular Diagnostic Tests For Genetic Diseases
    Worldwide, Laboratories Performing DNA Sequencing by Country
    Worldwide, Molecular Diagnostics Market Potential Laboratory Universe by Country
    Worldwide, Molecular Diagnostic Test Volume Forecast by Country
    Worldwide, Molecular Diagnostics Market Forecast by Country
    France Molecular Diagnostics Test Volume And Sales By Major Application
    France Laboratories Performing DNA Sequencing By Market Segment
    France Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
    France Molecular Diagnostics Test Volume By Major Application
    France Major Infectious Disease Test Volume by Assay
    France Major Infectious Disease Test Volume by Method
    France Molecular Diagnostics Market By Major Application
    France Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
    France Major Infectious Disease Diagnostics Market by Assay
    France AIDS Testing Market Estimated Sales by Major Supplier
    France Adenovirus Testing Market Estimated Sales by Major Supplier
    France Chlamydia Testing Market Estimated Sales by Major Supplier
    France CMV Testing Market Estimated Sales by Major Supplier
    France Gonorrhea Testing Market Estimated Sales by Major Supplier
    France Hepatitis Testing Market Estimated Sales by Major Supplier
    France Hepatitis C Testing Market Estimated Sales by Major Supplier
    France HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
    France Herpes Testing Market Estimated Sales by Major Supplier
    France Influenza Testing Market Estimated Sales by Major Supplier
    France Meningitis Testing Market Estimated Sales by Major Supplier
    France Mycoplasma Testing Market Estimated Sales by Major Supplier
    France RSV Testing Market Estimated Sales by Major Supplier
    France Shigella Testing Market Estimated Sales by Major Supplier
    Germany Molecular Diagnostics Test Volume And Sales By Major Application
    Germany Laboratories Performing DNA Sequencing By Market Segment
    Germany Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
    Germany Molecular Diagnostics Test Volume By Major Application
    Germany Major Infectious Disease Test Volume by Assay
    Germany Major Infectious Disease Test Volume by Method
    Germany Molecular Diagnostics Market By Major Application
    Germany Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
    Germany Major Infectious Disease Diagnostics Market by Assay
    Germany AIDS Testing Market Estimated Sales by Major Supplier
    Germany CMV Testing Market Estimated Sales by Major Supplier
    Germany EBV Testing Market Estimated Sales by Major Supplier
    Germany Gonorrhea Testing Market Estimated Sales by Major Supplier
    Germany Hepatitis Testing Market Estimated Sales by Major Supplier
    Germany Hepatitis C Testing Market Estimated Sales by Major Supplier
    Germany HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
    Germany Herpes Testing Market Estimated Sales by Major Supplier
    Germany Influenza Testing Market Estimated Sales by Major Supplier
    Germany Meningitis Testing Market Estimated Sales by Major Supplier
    Germany Mycoplasma Testing Market Estimated Sales by Major Supplier
    Germany Pneumonia Testing Market Estimated Sales by Major Supplier
    Germany RSV Testing Market Estimated Sales by Major Supplier
    Germany Rotavirus Testing Market Estimated Sales by Major Supplier
    Italy Molecular Diagnostics Test Volume And Sales By Major Application
    Italy Laboratories Performing DNA Sequencing By Market Segment
    Italy Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
    Italy Molecular Diagnostics Test Volume By Major Application
    Italy Major Infectious Disease Test Volume by Assay
    Italy Major Infectious Disease Test Volume by Method
    Italy Molecular Diagnostics Market By Major Application
    Italy Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
    Italy Major Infectious Disease Diagnostics Market by Assay
    Italy AIDS Testing Market Estimated Sales by Major Supplier
    Italy CMV Testing Market Estimated Sales by Major Supplier
    Italy Gonorrhea Testing Market Estimated Sales by Major Supplier
    Italy Hepatitis Testing Market Estimated Sales by Major Supplier
    Italy Hepatitis C Testing Market Estimated Sales by Major Supplier
    Italy HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
    Italy Herpes Testing Market Estimated Sales by Major Supplier
    Italy Influenza Testing Market Estimated Sales by Major Supplier
    Italy Meningitis Testing Market Estimated Sales by Major Supplier
    Italy Mycoplasma Testing Market Estimated Sales by Major Supplier
    Italy RSV Testing Market Estimated Sales by Major Supplier
    Japan Molecular Diagnostics Test Volume And Sales By Major Application
    Japan Laboratories Performing DNA Sequencing By Market Segment
    Japan Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
    Japan Molecular Diagnostics Test Volume By Major Application
    Japan Major Infectious Disease Test Volume by Assay
    Japan Major Infectious Disease Test Volume by Method
    Japan Molecular Diagnostics Market By Major Application
    Japan Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
    Japan Major Infectious Disease Diagnostics Market by Assay
    Japan AIDS Testing Market Estimated Sales by Major Supplier
    Japan Chlamydia Testing Market Estimated Sales by Major Supplier
    Japan CMV Testing Market Estimated Sales by Major Supplier
    Japan Gonorrhea Testing Market Estimated Sales by Major Supplier
    Japan Hepatitis Testing Market Estimated Sales by Major Supplier
    Japan Hepatitis C Testing Market Estimated Sales by Major Supplier
    Japan Herpes Testing Market Estimated Sales by Major Supplier
    Japan Meningitis Testing Market Estimated Sales by Major Supplier
    Japan Mycoplasma Testing Market Estimated Sales by Major Supplier
    Japan Pneumonia Testing Market Estimated Sales by Major Supplier
    Japan Shigella Testing Market Estimated Sales by Major Supplier
    Spain Molecular Diagnostics Test Volume And Sales By Major Application
    Spain Laboratories Performing DNA Sequencing By Market Segment
    Spain Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
    Spain Molecular Diagnostics Test Volume By Major Application
    Spain Major Infectious Disease Test Volume by Assay
    Spain Major Infectious Disease Test Volume by Method
    Spain Molecular Diagnostics Market By Major Application
    Spain Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
    Spain Major Infectious Disease Diagnostics Market by Assay
    Spain AIDS Testing Market Estimated Sales by Major Supplier
    Spain Chlamydia Testing Market Estimated Sales by Major Supplier
    Spain CMV Testing Market Estimated Sales by Major Supplier
    Spain Gonorrhea Testing Market Estimated Sales by Major Supplier
    Spain Hepatitis Testing Market Estimated Sales by Major Supplier
    Spain Hepatitis C Testing Market Estimated Sales by Major Supplier
    Spain HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
    Spain Herpes Testing Market Estimated Sales by Major Supplier
    Spain Influenza Testing Market Estimated Sales by Major Supplier
    Spain Meningitis Testing Market Estimated Sales by Major Supplier
    Spain Mycoplasma Testing Market Estimated Sales by Major Supplier
    U.K. Molecular Diagnostics Test Volume And Sales By Major Application
    U.K. Laboratories Performing DNA Sequencing By Market Segment
    U.K. Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
    U.K. Molecular Diagnostics Test Volume By Major Application
    U.K. Major Infectious Disease Test Volume by Assay
    U.K. Major Infectious Disease Test Volume by Method
    U.K. Molecular Diagnostics Market By Major Application
    U.K. Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
    U.K. Major Infectious Disease Diagnostics Market by Assay
    U.K. AIDS Testing Market Estimated Sales by Major Supplier
    U.K. Gonorrhea Testing Market Estimated Sales by Major Supplier
    U.K. Hepatitis Testing Market Estimated Sales by Major Supplier
    U.K. Hepatitis C Testing Market Estimated Sales by Major Supplier
    U.K. HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
    U.K. Influenza Testing Market Estimated Sales by Major Supplier
    U.K. Mycoplasma Testing Market Estimated Sales by Major Supplier
    U.K. Pneumonia Testing Market Estimated Sales by Major Supplier
    U.K. Shigella Testing Market Estimated Sales by Major Supplier
    U.S.A. Molecular Diagnostics Test Volume And Sales By Major Application
    U.S.A. Laboratories Performing DNA Sequencing By Market Segment
    U.S.A. Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
    U.S.A. Molecular Diagnostics Test Volume by Major Application
    U.S.A. Major Infectious Disease Test Volume by Assay
    U.S.A. Major Infectious Disease Test Volume by Method
    U.S.A. Molecular Diagnostics Market By Major Application
    U.S.A. Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
    U.S.A. Major Infectious Disease Diagnostics Market by Assay
    U.S.A. AIDS Testing Market Estimated Sales by Major Supplier
    U.S.A. Adenovirus Testing Market Estimated Sales by Major Supplier
    U.S.A. Chlamydia Testing Market Estimated Sales by Major Supplier
    U.S.A. CMV Testing Market Estimated Sales by Major Supplier
    U.S.A. Echovirus Testing Market Estimated Sales by Major Supplier
    U.S.A. Enterovirus Testing Market Estimated Sales by Major Supplier
    U.S.A. EBV Testing Market Estimated Sales by Major Supplier
    U.S.A. Gonorrhea Testing Market Estimated Sales by Major Supplier
    U.S.A. Hepatitis Testing Market Estimated Sales by Major Supplier
    U.S.A. Hepatitis C Testing Market Estimated Sales by Major Supplier
    U.S.A. HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
    U.S.A. Herpes Testing Market Estimated Sales by Major Supplier
    U.S.A. Influenza Testing Market Estimated Sales by Major Supplier
    U.S.A. Meningitis Testing Market Estimated Sales by Major Supplier
    U.S.A. Mycoplasma Testing Market Estimated Sales by Major Supplier
    U.S.A. Pneumonia Testing Market Estimated Sales by Major Supplier
    U.S.A. Rabies Testing Market Estimated Sales by Major Supplier
    U.S.A. RSV Testing Market Estimated Sales by Major Supplier
    U.S.A. Salmonella Testing Market Estimated Sales by Major Supplier
    U.S.A. Shigella Testing Market Estimated Sales by Major Supplier
    U.S.A. West Nile Virus Nat Market Reagent Sales by Major Supplier


    More Publications